MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers

Abstract The Fanconi Anemia (FA) pathway is essential for human cells to maintain genomic integrity following DNA damage. This pathway is involved in repairing damaged DNA through homologous recombination. Cancers with a defective FA pathway are expected to be more sensitive to cross-link based ther...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wenrui Duan, Shirley Tang, Li Gao, Kathleen Dotts, Andrew Fink, Arjun Kalvala, Brittany Aguila, Qi-En Wang, Miguel A. Villalona-Calero
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/00e5274edafd4aabbc69514504bfd27d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:00e5274edafd4aabbc69514504bfd27d
record_format dspace
spelling oai:doaj.org-article:00e5274edafd4aabbc69514504bfd27d2021-12-02T15:52:59ZMiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers10.1038/s41598-021-83884-92045-2322https://doaj.org/article/00e5274edafd4aabbc69514504bfd27d2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83884-9https://doaj.org/toc/2045-2322Abstract The Fanconi Anemia (FA) pathway is essential for human cells to maintain genomic integrity following DNA damage. This pathway is involved in repairing damaged DNA through homologous recombination. Cancers with a defective FA pathway are expected to be more sensitive to cross-link based therapy or PARP inhibitors. To evaluate downstream effectors of the FA pathway, we studied the expression of 734 different micro RNAs (miRNA) using NanoString nCounter miRNA array in two FA defective lung cancer cells and matched control cells, along with two lung tumors and matched non-tumor tissue samples that were deficient in the FA pathway. Selected miRNA expression was validated with real-time PCR analysis. Among 734 different miRNAs, a cluster of microRNAs were found to be up-regulated including an important cancer related micro RNA, miR-200C. MiRNA-200C has been reported as a negative regulator of epithelial-mesenchymal transition (EMT) and inhibits cell migration and invasion by promoting the upregulation of E-cadherin through targeting ZEB1 and ZEB2 transcription factors. miRNA-200C was increased in the FA defective lung cancers as compared to controls. AmpliSeq analysis showed significant reduction in ZEB1 and ZEB2 mRNA expression. Our findings indicate the miRNA-200C potentially play a very important role in FA pathway downstream regulation.Wenrui DuanShirley TangLi GaoKathleen DottsAndrew FinkArjun KalvalaBrittany AguilaQi-En WangMiguel A. Villalona-CaleroNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Wenrui Duan
Shirley Tang
Li Gao
Kathleen Dotts
Andrew Fink
Arjun Kalvala
Brittany Aguila
Qi-En Wang
Miguel A. Villalona-Calero
MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers
description Abstract The Fanconi Anemia (FA) pathway is essential for human cells to maintain genomic integrity following DNA damage. This pathway is involved in repairing damaged DNA through homologous recombination. Cancers with a defective FA pathway are expected to be more sensitive to cross-link based therapy or PARP inhibitors. To evaluate downstream effectors of the FA pathway, we studied the expression of 734 different micro RNAs (miRNA) using NanoString nCounter miRNA array in two FA defective lung cancer cells and matched control cells, along with two lung tumors and matched non-tumor tissue samples that were deficient in the FA pathway. Selected miRNA expression was validated with real-time PCR analysis. Among 734 different miRNAs, a cluster of microRNAs were found to be up-regulated including an important cancer related micro RNA, miR-200C. MiRNA-200C has been reported as a negative regulator of epithelial-mesenchymal transition (EMT) and inhibits cell migration and invasion by promoting the upregulation of E-cadherin through targeting ZEB1 and ZEB2 transcription factors. miRNA-200C was increased in the FA defective lung cancers as compared to controls. AmpliSeq analysis showed significant reduction in ZEB1 and ZEB2 mRNA expression. Our findings indicate the miRNA-200C potentially play a very important role in FA pathway downstream regulation.
format article
author Wenrui Duan
Shirley Tang
Li Gao
Kathleen Dotts
Andrew Fink
Arjun Kalvala
Brittany Aguila
Qi-En Wang
Miguel A. Villalona-Calero
author_facet Wenrui Duan
Shirley Tang
Li Gao
Kathleen Dotts
Andrew Fink
Arjun Kalvala
Brittany Aguila
Qi-En Wang
Miguel A. Villalona-Calero
author_sort Wenrui Duan
title MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers
title_short MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers
title_full MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers
title_fullStr MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers
title_full_unstemmed MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers
title_sort mirna-200c expression in fanconi anemia pathway functionally deficient lung cancers
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/00e5274edafd4aabbc69514504bfd27d
work_keys_str_mv AT wenruiduan mirna200cexpressioninfanconianemiapathwayfunctionallydeficientlungcancers
AT shirleytang mirna200cexpressioninfanconianemiapathwayfunctionallydeficientlungcancers
AT ligao mirna200cexpressioninfanconianemiapathwayfunctionallydeficientlungcancers
AT kathleendotts mirna200cexpressioninfanconianemiapathwayfunctionallydeficientlungcancers
AT andrewfink mirna200cexpressioninfanconianemiapathwayfunctionallydeficientlungcancers
AT arjunkalvala mirna200cexpressioninfanconianemiapathwayfunctionallydeficientlungcancers
AT brittanyaguila mirna200cexpressioninfanconianemiapathwayfunctionallydeficientlungcancers
AT qienwang mirna200cexpressioninfanconianemiapathwayfunctionallydeficientlungcancers
AT miguelavillalonacalero mirna200cexpressioninfanconianemiapathwayfunctionallydeficientlungcancers
_version_ 1718385490127749120